General Information
Product name
Voriconazole for Injection
Product name
Voriconazole for Injection
Identification on the label/Trade name
VFEND , Voriconazole
Product Synonyms
Voriconazole
Chemical name
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4 pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol and 2-Hydroxypropy-.beta.-cyclodextrin
CAS No.
128446-35-5
Emergency telephone
1-800-222-1222
Icons in SDS
Company Information
company name
X-GEN Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Potential Acute Health Effects
This is a medicinal product that may affect body functions. When inside vials the hazard is considered negligible. May produce slight eye irritation.
Potential chronic health
Effects Voriconazole may produce slight eye irritation Carcinogenic Effects: Not available Mutagenic Effects: Not available
Teratogenic Effects
Animal studies indicate that this material may cause adverse effects on the liver, the developing fetus. Developmental Toxicity: Classified development toxin (possible). The substance may be toxic to the liver. Repeated or prolonged exposure to the substance can produce target organ damage. Adverse effects: The substance is possibly harmful for the aquatic environment, due to its antibiotic properties. The most common adverse effects reported with clinical use of voriconazole include visual disturbance, elevations of liver function tests and skin rash. Voriconazole has been associated with photosensitivity skin reactions especially during long term therapy.
